SEC Form 4 · accession 0001493152-15-002665
OncBioMune Pharmaceuticals, Inc · OBMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Leone Group, LLC
10% Owner
Period of report
May 18, 2015
Accepted (ET)
Jun 26, 2015 · 9:26 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001362703
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 18, 2015 | S | 17,774,136 | $0.0001 | D | 132,893,954 | D | |
| Common StockF1 | Jun 17, 2015 | J | 3,188,546 | $0.003 | A | 136,082,500 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On June 17, 2015, the reporting person acquired these shares through settlement of $9,565.64 of debt of the issuer held by the reporting person.